About
PRECISIS develops a minimally invasive neurostimulation system called EASEE® for treating medication-resistant focal epilepsy by implanting a device under the scalp to target seizure origins without brain surgery.
Explore PRECISIS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.